Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

CRIS

Curis (CRIS)

Curis Inc
Von:
Sortieren nach:
 Showing the most relevant articles for your search:NASDAQ:CRIS
DatumZeitQuelleÜberschriftSymbolFirma
10/05/202414h00PR Newswire (US)Curis to Present Updated Data from the TakeAim Leukemia StudyNASDAQ:CRISCuris Inc
07/05/202414h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRISCuris Inc
07/05/202414h02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
07/05/202414h00PR Newswire (US)Curis Provides First Quarter 2024 Business UpdateNASDAQ:CRISCuris Inc
30/04/202414h00PR Newswire (US)Curis to Release First Quarter 2024 Financial Results and Hold Conference Call on May 7, 2024NASDAQ:CRISCuris Inc
05/04/202413h30PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
04/04/202413h30PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in AprilNASDAQ:CRISCuris Inc
12/02/202422h16Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:CRISCuris Inc
08/02/202422h36Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:CRISCuris Inc
08/02/202422h27Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:CRISCuris Inc
08/02/202422h01Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:CRISCuris Inc
08/02/202414h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
08/02/202414h00PR Newswire (US)Curis Provides Fourth Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
01/02/202414h00PR Newswire (US)Curis to Release Fourth Quarter 2023 Financial Results and Hold Conference Call on February 8, 2024NASDAQ:CRISCuris Inc
11/01/202414h13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
05/01/202414h00PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
21/12/202322h00Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:CRISCuris Inc
12/12/202314h00PR Newswire (US)Curis Announces Initial Combination Study Data from its TakeAim Lymphoma StudyNASDAQ:CRISCuris Inc
11/12/202314h00PR Newswire (US)Curis Presented Clinical Data from the TakeAim Leukemia Study at the 2023 ASH ConferenceNASDAQ:CRISCuris Inc
06/12/202314h00PR Newswire (US)Curis Announces Three Presentations at ASHNASDAQ:CRISCuris Inc
05/12/202314h00PR Newswire (US)Curis Enters into Agreement for Emavusertib / Pembrolizumab Combination Study in MelanomaNASDAQ:CRISCuris Inc
02/11/202313h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CRISCuris Inc
02/11/202313h01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
02/11/202313h00PR Newswire (US)Curis Provides Third Quarter 2023 Business UpdateNASDAQ:CRISCuris Inc
26/10/202314h30PR Newswire (US)Curis to Release Third Quarter 2023 Financial Results and Hold Conference Call on November 2, 2023NASDAQ:CRISCuris Inc
06/10/202314h56PR Newswire (US)Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:CRISCuris Inc
28/09/202322h05Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:CRISCuris Inc
28/09/202314h54Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CRISCuris Inc
12/09/202314h00PR Newswire (US)Curis Announces Date for the 2nd Symposium on IRAK4 in CancerNASDAQ:CRISCuris Inc
06/09/202314h13PR Newswire (US)Curis to Present at Upcoming Healthcare Conferences in SeptemberNASDAQ:CRISCuris Inc
 Showing the most relevant articles for your search:NASDAQ:CRIS

Kürzlich von Ihnen besucht

Delayed Upgrade Clock